Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the genetics of type 2 diabetes are poorly understood and under intense investigation in this era of precision medicine (52).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Self-citationGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Research works printed but not linked: 1
- Rewers M, Stene LC, Norris JM Chapter 11: Risk factors for type 1 diabetes. In Diabetes in America, 3rd ed Cowie CC, Casagrande SS, Menke A,, Eds. Bethesda, MD, National Institutes of Health, 2018
Cited by
Items 301–400 of 401
Biomarkers of Diabetic Foot Ulcers and Its Healing Progress
Niewczas, M. A., & Shah, H. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_18 · Cited by 3
Javed, A., Tariq, M., Hussain, G., Ali, S., Fatima, A., Batool, A., Khalid, D., Noor, Z., & Rasul, S. (2024) · Developmental medico-life-sciences · doi:10.69750/dmls.01.06.058 · Cited by 4
The intervention effect of comprehensive precision nursing in elderly patients with type 2 diabetes
Gao, H., Han, Y., Deng, D., & Liu, L. (2025) · Australian Journal on Ageing · doi:10.1111/ajag.70047 · Cited by 2
Präzisionsmedizin unter Nutzung der elektronischen Diabetesakte
Verket, M., Ickrath, M., Haizmann, M., Geldhäuser, R., Vité, S., Bitzer, B., & Müller‐Wieland, D. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00826-9 · Cited by 1
Hamann, A. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00783-3 · Cited by 1
Precision Exercise and Physical Activity for Diabetes
Boulé, N. G., & Yardley, J. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_13 · Cited by 1
Getting it right first time – precision medicine in diabetes
Kilvert, A., & Fox, C. (2022) · Practical Diabetes · doi:10.1002/pdi.2419 · Cited by 1
FREQUENCY OF COMMON CAUSES OF SEVERE HYPERBILIRUBINEMIA IN NEONATES LEADING TO EXCHANGE TRANSFUSION
MUHAMMAD, B., Nargis, T., Shaheen, R., & Jehanzeb, S. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.441 · Cited by 1
Al‐Sari, N., Kutuzova, S., Suvitaival, T., Henriksen, P., Pociot, F., Rossing, P. R., McCloskey, D., & Legido‐Quigley, C. (2021) · medRxiv · doi:10.1101/2021.09.28.21264161 · Cited by 1
From diabetes to heart disease
Mijolović, Ž., Golubović, S., Mioković, I. K., & Komosar-Cvetković, M. (2021) · Cardiologia Croatica · doi:10.15836/ccar2021.334 · Cited by 1
Wu, C., Ge, Y., Xinyan, Z., MingChao, L., Chunni, H., Linyuan, Z., Yanling, D., He, S., Lei, S., & Hongjuan, L. (2021) · Research Square · doi:10.21203/rs.3.rs-200389/v1 · Cited by 2
Editorial Cycles and Continuity of Diabetes Care
Riddle, M. C., Aroda, W. A. O. B. O. A. E. V., Bakris, G. L., Blonde, L., Boulton, A. J. M., Castle, J. R., DiMeglio, L. A., Gonder-Frederick, L. A., Hu, F. B., Kahn, S. E., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0020 · Cited by 2
Li, X., Zhang, M., Yan, J., & Liu, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1120555 · Cited by 1
Igudesman, D., Nally, L. M., Grimshaw, A. A., Gunderson, C. G., Considine, E. G., Jacobsen, L., Tosur, M., Gottlieb, P., Hirsch, I. B., Laffel, L., et al. (2025) · medRxiv · doi:10.1101/2025.05.23.25328241 · Cited by 4
Ruiz Gracia, T., Nattero-Chávez, L., Arranz Martín, A., de la Calle de la Villa, E., Lorenzo Moñino, M., Bayona Cebada, A., Corral, M. I., Quintero Tobar, A., Lahera Vargas, M., Jiménez Blanco, S., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113505
Precision Diagnostics for Type 2 Diabetes Mellitus — Have We Arrived?
Colling, C., & Rosen, C. J. (2022) · NEJM Evidence · doi:10.1056/evide2200039
Aiming Precision Medicine at Chronic Diseases
May, M. J. (2022) · Inside Precision Medicine · doi:10.1089/ipm.09.04.08
A New Bar for Pharmacologic Weight Loss: Type 2 Diabetes Prevention
Dungan, K. M. (2022) · Diabetes Care · doi:10.2337/dci22-0019
Serum Leptin as a Biomarker in Diabetes: Links with Acromegaly
Ahmed, H. S. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_50
Efficience et précision du contrôle glycémique dans le diabète : symphonie inachevée ?
Monnier, L., Halimi, S., & Colette, C. (2022) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2022.11.005
Diabetes, genética y epigenética: cómo aplicar la medicina personalizada de precisión
Carrasco, A. J. B. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/2022.1/art2
La medicina de precisión en diabetes es posible
de la Puente, J. B. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/2022.1/art1
Einfache Einteilung der Subtypen des Diabetes in der Praxis: Ein Kommentar
Fritsche, A. (2023) · Die Diabetologie · doi:10.1007/s11428-022-00992-4
Accelerating data-driven discover in type 1 diabetes: an informatics-based approach
Tallon, E. M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94294
Precision Medicine in Diabetes: state of the art based on recent Consensus
Briatore, L. (2022) · The Journal of AMD · doi:10.36171/jamd22.25.4.6
Current Strategies of New Drugs for Diabetes Management
Sarfraz, M., Hafizur, R. M., Ullah, H., Sajid, S., Akhtar, R. W., Noreen, M., Perveen, S., & Khan, M. U. (2023) · Frontiers in clinical drug research. Diabetes and obesity · doi:10.2174/9789815123586123070005
Han, X., Xue, P., Yang, J., Wang, L., Li, Z., Wei, M., & Ma, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-2750981/v1
Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk
Franks, P. W. (2023) · Diabetes Care · doi:10.2337/dci22-0066
Bodhini, D., Morton, R. W., Santhakumar, V., Nakabuye, M., Pomares‐Millan, H., Clemmensen, C., Fitzpatrick, S. L., Guasch‐Ferré, M., Pankow, J. S., Ried‐Larsen, M., et al. (2023) · medRxiv · doi:10.1101/2023.05.03.23289433
Advances in Precision Medicine Approaches for Type 2 Diabetes Management: A Comprehensive Review
Milla-Amekor, E., & Ewusie, E. A. (2023) · Asian Journal of Research in Medical and Pharmaceutical Sciences · doi:10.9734/ajrimps/2023/v12i3220 · Cited by 2
Shamsaei, G., Zakerkish, M., Kashipazha, D., Moradi, M., & Zakizadeh, H. (2023) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2023.17.1-77
Mul, D., Varkevisser, R. D. M., Aanstoot, H., Dekker, P., Birnie, E., Boersma, H. E., Boesten, L. S. M., Brugts, M. P., van Dijk, P. R., Geelhoed-Duijvestijn, P. H. L. M., et al. (2023) · medRxiv · doi:10.1101/2023.08.17.23294197
Luqman Hakim Boarding Students Training Rowolaku In Effective Financial Management And Efficient
Yuliana, S., Pramuditha, S., Karima, N., Agelia, E., Adinugraha, H. H., & Baron, G. (2023) · Pengabdian Jurnal Abdimas · doi:10.55849/abdimas.v1i3.196
Acar, A. B. (2023) · Cureus · doi:10.7759/cureus.45650 · Cited by 1
Precision medicine: monogenic diabetes
Rabbone, I. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.9
Introduction: A Multi-Pronged Approach to CKD Associated With Type 2 Diabetes
Singh, A. K., & Agarwal, R. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151444
Loss of Muscle Mass in Delayed Diagnosis of Renal Cysts and Diabetes Syndrome: A Case Report
Li, X., Cao, Y., Gu, N., & Yuan, Z. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s430096
FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH COVID-19 INFECTION
Ruidar, S. B., Ning, W., Ullah, N., Khan, M. D. U., & Mijiti, Y. (2023) · doi:10.53555/jptcp.v30i19.3624
Research Progress on Clinical Classification of Diabetes Based on Precision Medicine
张, 玉. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141019
Characterization and Subgrouping of Type 2 Diabetes
Cho, Y. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.4.199
Other Disorders with Type 1 Diabetes and Atypical Phenotypes
Kong, A. P. S., Chow, E., Luk, A. O. Y., & Chan, J. C. N. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch15
Biomedical Interventions in Precision Medicine for Diabetics
Madhumitha, A., & Dhananjayan, V. (2023) · International Conference on Smart Technologies, Communication and Robotics (STCR) · doi:10.1109/stcr59085.2023.10397058
The Scope of Precision Medicine in Management of Type 2 Diabetic Patients with Hypertension
A, B. P., & Varne, S. R. R. (2024) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2024/v16i1353
Khdir, D., & Mohammed, M. (2023) · Journal of Zankoy Sulaimani - Part A · doi:10.17656/jzs.10892
FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH COVID-19 INFECTION
Ahmad, A., Saahil, K., Ameer, A., Amina, A., Kumar, M., & Shaikh, A. A. (2024) · doi:10.53555/jptcp.v31i3.5130
Mohammed, P., & Amin, K. (2023) · Journal of Zankoy Sulaimani - Part A · doi:10.17656/jzs.10949 · Cited by 1
Diabetic bone disease: Metabolic and microvascular damage
Muñoz‐Torres, M., Hayón-Ponce, M., & García-Fontana, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00008-7
Alomari, A. O. M., Aljohani, M. S. A., Alharbi, M. S. M., Balawi, S. S. F. A., Albalawi, M. S. H., Aljohani, A. A. A., Albalawi, M. M. M., Alenazi, K. A., Alalwani, Y. E. S., Albalawi, A. A. A., et al. (2022) · Journal of Survey in Fisheries Sciences · doi:10.53555/sfs.v9i3.2524
Katagiri, Y., Ozaku, H., & Kondo, K. (2024) · Frontiers in Sensors · doi:10.3389/fsens.2024.1382152
Cetoacidose metabólica: condições clínicas e abordagens terapêuticas
Frazão, L. F. N., de Oliveira, J. M. G., Pereira, M. M., Ramos, J. L. B., dos Santos, D. R. L., Neto, O. B. D. O., Matos, J. P. A., Santos, T. G. D., dos Santos, M. M., dos Santos, G. D., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n5p1035-1043
Wang, J., & Ling, Z. (2024) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0033
Large-scale systematic review support for guideline development in diabetes precision medicine
Björklund, M., & Aronsson, K. (2024) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2024.1863
Nuevas propuestas de la clasificación de diabetes: revisión narrativa
Herrera, G. J. M., & Mendoza-Fuentes, M. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.3.870 · Cited by 1
Medicina de precisão genética em obesidade e diabetes
Silva, M. R., Teixeira, V. B. D. S., & Utagawa, C. Y. (2024) · Cadernos UniFOA · doi:10.47385/cadunifoa.v19.n54.5211
Valadares, J. V. P., & Ferreira, E. D. F. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n12-112
Blanco-Carrasco, A. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-69895-8_51
Wang, K., Noordam, R., Trompet, S., van Oortmerssen, J. A. E., Jukema, J. W., Ikram, M. K., Nano, J., Herder, C., Peters, A., Gieger, C., et al. (2025) · medRxiv · doi:10.1101/2025.03.09.25323601
Song, X., Wu, L., Zhou, H., Li, X., Chen, Y., & Zhang, W. (2025) · Research Square · doi:10.21203/rs.3.rs-6191546/v1
Prouvot, J., Reboul, P., Ahmadpoor, P., Clemmer, E., Gerbal, M., Garo, F., Cariou, S., Pambrun, E., Messikh, Z., & Moranne, O. P. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02286-6
Individualized Therapy Optimization for Type 2 DiabetesPreprint
Lozhkina, A., Piazza, C., Gabr, Z., Rupp, M., Herzig, D., Bally, L., & Jaun, A. (2025) · medRxiv · doi:10.1101/2025.10.13.25337959
Garg, S., Kitchen, R. R., Gupta, R., Trucco, E., & Pearson, E. R. (2025) · JMIR Diabetes · doi:10.2196/82635 · Cited by 1
Multimorbidity measurement strategies for predicting hospital visits
Neves, B. D., Moreira, J. M., Gonçalves, S., Cerejo, J., Mota, I., Silva, N. A., Leite, F., & Silva, M. J. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13817-z
de Vries, R., Reinders, E. F. H., de Carvalho, D. F., de Meulengraaf, E. M. W. L. C. V., Gorp, P. M. E. V., Poppel, P. W., Kaymak, U., Hilbers, P. A. J., van Riel, N. A. W., & Haak, H. R. (2026) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702261416447
Elyeli, K., & Esmaeilzadeh, S. (2026) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000001334
Moin, H., Asad, M., Waseem, M., Zafar, S., Syed, H., Syed, R., & Hussain, M. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/5528647
Wang, W., Ma, Y., Chen, Z., Qiao, J., Xiao, P., Wei, R., Jiang, X., Gao, D., Shao, J., Yu, J., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003953
Singh, P., Tripathy, D. B., & Kumar, G. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01843-x · Cited by 2
Carew, A. S., Urquhart, R., Aston, M. L., Wang, J. L., Grove, J., More, S., Siddiqi, F. S., Sapp, J. L., & Cahill, L. E. (2026) · CJC Open · doi:10.1016/j.cjco.2026.02.010 · Cited by 1
Roney, M., Gazali, A. M., Akter, S., & Aluwi, M. F. F. M. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-026-00762-y
Immune-targeted therapies: Management of diabetes and fostering healthy aging
Nainu, F., Ophinni, Y., Mamada, S. S., & Latada, N. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00024-9
Definition and Epidemiology of Type 2 Diabetes Mellitus
Ke, C., Chan, J. C. N., & Lim, L.-L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00001-x
Garcia-Coste, J. J., Aguayo-Cerón, K. A., Espinosa‐Raya, J., García-Rivero, A. A., López-Leyva, C., Gutiérrez-Rojas, R. A., Vargas‐De‐León, C., & Romero‐Nava, R. (2026) · Medical Sciences · doi:10.3390/medsci14010128
Future prospective and challenges in neurobiology of type 2 diabetes
Dubey, M., Ranjan, S., & Kumar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00016-9
Mori, T., Kuß, O., Mader, J. K., Naudorf, M., Seufert, J., Holl, R. W., Lanzinger, S., & Grimsmann, J. M. (2026) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2798-6496 · Cited by 1
Prediction of maturity-onset diabetes of the young subtypes using machine learning
Figueroa, I., Flores, R., Millán, A. L., Dios, A. D., Frechtel, G. D., López, A. P., & Mennickent, D. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1656161
Aralıklı oruç ile tip 2 diyabet ilişkisi: geleneksel derleme
Karadoğan, S. R., & Canbolat, E. (2026) · Sağlık akademisyenleri dergisi/Sağlık akademisyenler dergisi · doi:10.52880/sagakaderg.1690303
Editorial: Uncommon or rare forms of diabetes: from diagnosis to management
Grancini, V., & Bolla, A. M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1831564
Xu, M., Gan, H., Zhong, F., Qiao, M., Ren, P., Zhu, Y., Wang, Q., & Wu, W. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00762-x · Cited by 2
Glatzer, T., Peak, A., Leppäaho, E., Lustenberger, P., Herrero, P., Andorrà, M., & van Maren, E. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261438523
Diabetes Risk Progression and Personalized Recommendations Using Machine Learning
Shekhar, H., Ojha, G., Gupta, P., & Upender, P. (2026) · Springer eBooks · doi:10.1007/978-981-95-4831-6_24
Kamińska, H., Wieczorek, W., Pruc, M., Janeczko, M., Siudak, Z., & Szarpak, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1837746
Moreno-Fernández, J., Montoro, J. I. M., Muñoz‐Rodríguez, J. R., Herranz-Antolín, S., Marco, A., Pinés, P. J., de Ancos, M. R., González, J., Maqueda, E., Sastre, J., et al. (2026) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2026.107450
Varghese, J. S., Guo, J., Hua, D., Hung, T., Li, Z. T., Tang, S., Patel, S. A., & Ho, J. C. (2026) · medRxiv · doi:10.64898/2026.06.01.26354645
Integrating immunogenetics in T2DM research and practices
Binty, Shukla, U., Singh, M., Rachana, R., & Mani, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00001-0
Global Burden of Diabetes and Public Health Implications of Immuno-Metabolic Interventions
Feng, C. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202624001004 · Cited by 1
Genetics of Monogenic Forms of Diabetes
Naylor, R. N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00013-5
Dizdarević-Bostandžić, A., Hadzigrahic, E., & Nišić, A. (2026) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2026-001616
Kitazawa, M., Katagiri, T., Suzuki, H., Yamada, M., Hatta, M., TAKIZAWA, H., Murai, K., Sato, T., Matsubayashi, Y., Yamada, T., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71211
Swallowable micro-/nanorobots for disease treatment
Huang, J., Li, S., Bi, C., Chen, Y., Liu, W., & Liu, L. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb01257d
梅彩霞, Li, Y., Ma, H., Li, X., & Jiang, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1929060
Mukherjee, A. G., Bharti, A. K., Mathew, D. M., Gopalakrishnan, A. V., & Nishu, S. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10274-9
Genetic Variants Associated with Response to GLP-1 Receptor Agonists in Diabetes and Obesity
Fernandes, M. T., Dias, J. C., Espírito‐Santo, M., Estêvão, M. D., & Sousa‐Coelho, A. L. D. (2026) · Life · doi:10.3390/life16091486
Long, Q., Kang, S., He, Q., Wang, H., Qi, X., Lin, S., Song, X., Guo, Q., & Liu, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1935387
Ma, Y.-F., Neng, Q.-L., Ou, Y., & Zhou, Y. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/2572581
Lozhkina, A., Piazza, C. D., Gabr, Z., Rupp, M. E., Herzig, D., Bally, L., & Jaun, A. Y. R. (2026) · JMIR Formative Research · doi:10.2196/92877
Biyabani, S. (2026) · International Journal of Community Pharmacy · doi:10.65301/ijcp.2026.8.3.14
Gan, S., Choi, H., Lee, D. Y., Choi, C.-J., Koh, J. S., Jeong, C., Seo, W., Kwon, J., Park, R. W., & Park, I. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121518
Hoffmann, K., Pucek, W. F., Skrzypek, W., Kierzkowski, F., Ratajczak, P., Maggio, V., Rizzo, M., El-Tanani, M., Rabbani, S. A., Bhongade, B. A., et al. (2026) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2026.17560
The β-cell stress continuum: Molecular mechanisms driving diabetes progression and cellular failure
Jalalinezhad, A., Zamani, M., & Soltani, N. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168518
Metadata
- Authors
- Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., Philipson, L., McElvaine, A. T., Cefalu, W. T., Rich, S. S., & Franks, P. W.
- Affiliations
- Columbia University Irving Medical Center (US)
- American Diabetes Association (US)
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- University of Exeter (GB)
- Harvard University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Centre for Human Genetics (GB)
- Trinity College Dublin (IE)
- Colorado School of Public Health (US)
- University of Dundee (GB)
- University of Chicago (US)
- Duke University (US)
- University of Virginia (US)
- Corresponding author
- Franks, Paul W.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-11
- Volume
- 43
- Issue
- 7
- Pages
- 1617-1635
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7305007
- OpenAlex
- W3036199105
- Cited by
- 400
- References
- 136
- Citations by year
- 2026: 50 · 2025: 57 · 2024: 74 · 2023: 92 · 2022: 72 · 2021: 47 · 2020: 8
- FWCI
- 41.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Funders
- American Diabetes Association (1-15-ACE-26)
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Regeneron Pharmaceuticals
- Wellcome Trust (212259, 098381, 098395, 098395/Z/12/Z, 203141, 102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219, NF-SI-0617-10090)
- European Commission (115317, 115881, 875534, 098381)
- Lunds Universitet
- Novo Nordisk
- Vetenskapsrådet
- Universitetet i Bergen
- Servier
- National Institutes of Health (5r21ai142483-02, DK26687, UL1TR001873)
- Genentech
- Medical Research Council (MR/K005707/1, MR/T032014/1)
- National Institute of Allergy and Infectious Diseases (R21-AI142483)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, R01DK104942, 212259, R01DK052431, R01DK122586, U01DK105535, DP3DK111906, DK 26687, DK104351, R01DK104351, DK122586, 098381, 203141, P30DK026687, U54DK118612, P30DK020595, DK-52431)
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
- University of Colorado School of Medicine, Anschutz Medical Campus
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- precision medicine, diabetes mellitus, precision diagnostics, precision therapy, monogenic diabetes, diabetes prevention, diabetes treatment, implementation barriers, personalized medicine, diabetes phenotypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Europe, Financial Management, Health Plan Implementation, Humans, Practice Patterns, Physicians', Quality of Life, Societies, Medical, United States, Evidence-Based Medicine, Consensus, Biomedical Research, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.